CymaBay Therapeutics Inc. (CBAY)
NASDAQ: CBAY
· Real-Time Price · USD
32.48
0.01 (0.03%)
At close: Mar 21, 2024, 9:00 PM
CymaBay Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -105.37M | -90.1M | -80.72M | -107.01M | -106M | -105.91M | -104.09M | -100.22M | -90M | -79.21M | -67.94M | -55.45M |
Depreciation & Amortization | 681K | 810K | 777K | 740K | 710K | 698K | 692K | 693K | 688K | 679K | 662K | 643K |
Stock-Based Compensation | 15.23M | 12.92M | 11.55M | 10.59M | 9.52M | 9.54M | 9.74M | 9.9M | 10M | 9.42M | 9.43M | 7.83M |
Other Working Capital | 2.9M | -1.74M | -3.31M | 28.34M | -895K | 3.67M | 6.52M | 9.96M | 4.04M | 139.98M | 291.46M | 292.84M |
Other Non-Cash Items | 19.06M | 16.03M | 14.69M | 13.62M | 14.03M | 12.61M | 9.63M | 6.62M | 3.32M | 1.4M | 940K | 297K |
Deferred Income Tax | -7.77M | -4.08M | -1.99M | n/a | n/a | 94K | 211K | 211K | 211K | 117K | n/a | n/a |
Change in Working Capital | 5.63M | 516K | 414K | 29.77M | -2.34M | 3.4M | 6.36M | 8.55M | 6.35M | -2.41M | -5.13M | -3.9M |
Operating Cash Flow | -72.53M | -63.91M | -55.28M | -52.29M | -84.08M | -79.57M | -77.46M | -74.23M | -69.43M | -70M | -62.04M | -50.58M |
Capital Expenditures | -445K | -278K | -289K | -343K | -148K | -128K | -117K | 14K | -80K | -87K | -108K | -115K |
Cash Acquisitions | -2.11M | -2.98M | 1.56M | 2.35M | 3.66M | 5.17M | 630K | 630K | 826K | 196K | 196K | 196K |
Purchase of Investments | -305.67M | -202.38M | -219.72M | -233.59M | -174.98M | -195.82M | -159.73M | -122.36M | -78.08M | -66.96M | -144.62M | -129.01M |
Sales Maturities Of Investments | 219.55M | 166.55M | 163.9M | 178.29M | 129.14M | 117.54M | 114.28M | 84.25M | 126.76M | 135.36M | 143.42M | 166.14M |
Other Investing Acitivies | 17.57M | 18.44M | -1.56M | -1.02M | -2.34M | -3.85M | 685K | -637K | -833K | -196K | -196K | -196K |
Investing Cash Flow | -86.57M | -36.11M | -56.12M | -55.64M | -45.98M | -78.42M | -45.58M | -38.09M | 48.59M | 68.32M | -1.3M | 37.02M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 345.77M | 343.04M | 94.13M | 93.08M | 24.55M | 119.71M | 142.89M | 143M | 118.45M | 23.38M | 184K | 85K |
Financial Cash Flow | 345.77M | 343.04M | 94.13M | 93.08M | 24.55M | 119.71M | 142.89M | 143M | 118.45M | 23.38M | 198K | 99K |
Net Cash Flow | 186.24M | 243.03M | -17.27M | -14.85M | -105.52M | -38.27M | 19.86M | 30.67M | 97.61M | 21.69M | -63.15M | -13.47M |
Free Cash Flow | -72.98M | -64.19M | -55.57M | -52.63M | -84.23M | -79.69M | -77.58M | -74.22M | -69.51M | -70.09M | -62.15M | -50.69M |